Peripal AG

Home Care is paramount to manage costs and productivity in the future healthcare markets. The vision of Peripal AG is to allow more patients to be treated at home and to reduce healthcare costs in the area of dialysis.
The company’s first product, the PeriSafe© system, solves the most problematic therapy step in home peritoneal dialysis: a manual connection of tubings that bears the risk of infection. It is a connection device that will make home dialysis easier and safer for elderly patients.
The current market volume of home peritoneal dialysis is $ 3.2bn and it is growing at 6% annually until 2025, driven by age, diabetes, and hypertension.
The company has received the market authorisation (CE mark) in Q1 2019 and requires CHF 2.5mio in Q2/Q3 2019 for the market entry and growth.